Headquarters
MEDICON VILLAGE, LUND, LUND 223 81, SE
LUND, LUND, SE
APOGLYX AB
From the company
ApoGlyx AB is a Swedish biopharmaceutical company founded in 2015 that develops first-in-class therapies based on aquaporin inhibitors. Its mission is to bring RG210179, a patented first-in-class Aquaporin-9 inhibitor for the treatment of acute pancreatitis, into a clinical development program. The company is located in Lund, within the Medicon Valley region.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.